No direct measurement of patients’ regret exists for either choice. The closest measure is a decision-regret score reported by bereaved caregivers, and no study we found follows patients who chose each path. This page gives sources and context and shows no figure.
A 2021 study in Frontiers in Oncology surveyed 298 bereaved caregivers of people who died of cancer. Caregivers whose relative had received aggressive end-of-life care reported significantly more decision regret on the Decision Regret Scale than caregivers whose relative had not. The study reports that such care occurs frequently in European health care and is associated with poorer mental health in bereaved caregivers.
A 2010 randomised trial in the New England Journal of Medicine, in patients with newly diagnosed metastatic non-small-cell lung cancer, compared early palliative care integrated with standard oncologic care against standard care alone. The early palliative care group had better quality of life and mood, less aggressive care at the end of life, and longer survival. The trial measured those outcomes and did not measure regret.
The two studies differ in design, population and country, and the caregiver study compared two groups it did not assign. Its label of aggressive care refers to treatment near the end of life, so it does not describe every decision to pursue cancer treatment.







